Characterization of CD30/CD30L⁺ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis

Table 1

CD30⁺ and CD30L⁺ T cells phenotype in the peripheral blood and synovial fluid of RA patients and controls.

RA patients ()	Sample	CD3^+; CD4^+	CD3^+; CD8^+	CD4^+; CD30^+	CD4^+; CD30L^+	CD8^+; CD30^+	CD8^+; CD30L^+	Treg	Treg CD30^+
Mean ± S.D.	PB	73.9 ± 12.5	23.8 ± 12.3	0.8 ± 0.7	2.9 ± 1.8	0.1 ± 0.2	2.1 ± 0.2	5.0 ± 3.8	12.5 ± 15.2
Mean ± S.D.	SF	58.0 ± 10.7	38.8 ± 11.2	8.6 ± 5.6	13.9 ± 10.4	0.3 ± 0.5	2.3 ± 3.2	13.8 ± 4.8	42.3 ± 14.7
Controls ()	Sample	CD3^+; CD4^+	CD3^+; CD8^+	CD4^+; CD30^+	CD4^+; CD30L^+	CD8^+; CD30^+	CD8^+; CD30L^+	Treg	Treg CD30^+
Mean ± S.D.	PB	72.3 ± 9.5	22.3 ± 10.2	0.3 ± 0.5	3.2 ± 0.9	0.3 ± 0.5	1.7 ± 1.7	4.5 ± 1.8	4.1 ± 4.3
Mean ± S.D.	SF	62.0 ± 7.1	33.0 ± 4.2	0.5 ± 0.7	10.0 ± 1.4	0.5 ± 0.7	6.9 ± 5.8	4.0 ± 2.8	19.0 ± 11.3